Aims: Reactive oxygen species (ROS)-mediated formation of mixed disulfides between critical cysteine residues in proteins and glutathione, a process referred to as protein S-glutathionylation, can lead to loss of enzymatic activity and protein degradation. Since mitochondria are a major source of ROS and a number of their proteins are susceptible to protein-S-glutathionylation, we examined if overexpression of mitochondrial thioltranferase glutaredoxin 2a (Grx2a) in macrophages of dyslipidemic atherosclerosis-prone mice would prevent mitochondrial dysfunction and protect against atherosclerotic lesion formation. Methods and results: We generated transgenic Grx2a Mac LDLRÀ/À mice, which overexpress Grx2a as an EGFP fusion protein under the control of the macrophage-specific CD68 promoter. Transgenic mice and wild type siblings were fed a high fat diet for 14 weeks at which time we assessed mitochondrial bioenergetic function in peritoneal macrophages and atherosclerotic lesion formation. Flow cytometry and Western blot analysis demonstrated transgene expression in blood monocytes and peritoneal macrophages isolated from Grx2a Mac LDLRÀ/À mice, and fluorescence confocal microscopy studies confirmed that Grx2a expression was restricted to the mitochondria of monocytic cells. Live-cell bioenergetic measurements revealed impaired mitochondrial ATP turnover in macrophages isolated from Grx2a Mac LDLRÀ/À mice compared to macrophages isolated from non-transgenic mice. However, despite impaired mitochondrial function in macrophages of Grx2a Mac LDLRÀ/À mice, we observed no significant difference in the severity of atherosclerosis between wildtype and Grx2a Mac LDLRÀ/À mice.
Introduction
The recruitment of circulating blood monocytes to sites of local inflammation, followed by their differentiation into mature macrophages is a rate limiting step in multiple physiological processes including wound repair, inflammation, pathogen clearance, and replacement of tissue-derived resident macrophages [1e3] . Macrophages, particularly M2 polarized macrophages involved in inflammation resolution, rely on mitochondria for the energetically efficient production of ATP via oxidative phosphorylation (OXPHOS) [4] . However, these cells can survive and function in hypoxic inflamed tissues and meet their energy demands during hypoxic stress via anaerobic glycolysis [5] . In the process of OXPHOS, electrons are transferred through complexes IeIV, generating the proton gradient that drives ATP synthesis. During this process, 0.2%e2.0% of the electrons leak from the respiratory chain, primarily from complex I and complex III, resulting in a constant low level of reactive oxygen species (ROS) formation [6] . These ROS are detoxified by mitochondrial antioxidant enzymes, including superoxide dismutase, peroxiredoxin(s) and glutathione peroxidase. However, there is evidence that during conditions of metabolic stress, ROS production increases dramatically, resulting in oxidative stress, mitochondrial dysfunction and damage [7e9] . During oxidative stress, ROS promote the oxidation of glutathione (GSH) to glutathione disulfides (GSSG), either directly or through the reduction of peroxides by glutathione peroxidases, which use GSH as an electron donor [10, 11] . Under physiological conditions, GSSG generated within the mitochondria is reduced by mitochondrial glutathione reductase (GR) and is converted back to GSH. However, under conditions of increased ROS production, GR is oxidatively inactivated, resulting in the accumulation of GSSG [12, 13] . The lack of a GSSG efflux system within the mitochondria makes this cellular compartment highly susceptible to dramatic decreases in the GSH/GSSG ratio, particularly under conditions of high ROS production and thus prone to oxidative thiol modifications of redox-sensitive proteins through a thiol-disulfide exchange process referred to as protein S-glutathionylation. This reversible formation of mixed disulfides between protein thiols and GSH had originally been proposed to be a defense mechanism against irreversible thiol oxidation, protecting mitochondria against oxidative damage. However, more recent evidence now suggests that protein-S-glutathionylation plays a critical role in enzyme regulation and redox-sensitive signaling pathways.
Protein-S-glutathionylation has now emerged as a major reversible posttranslational cysteine modification that can become perturbed under conditions of oxidative stress, leading to changes in the activity of proteins involved in transcription, DNA synthesis, protein turnover, apoptosis, signal transduction, and mitochondrial function [14e17] . The reduction of S-glutathionylated protein thiols under physiological conditions is relatively slow and requires enzymatic catalysis [10] . Thioredoxins (Trx) and protein-disulfide isomerases can catalyze protein deglutathionylation, but glutaredoxins (Grxs) have been shown to be far more effective and highly specific for GSH-containing mixed disulfides [18] . Two Grx isoforms are present in mammalian cells, Grx1 and Grx2. Grx1 is localized in the cytosol and mitochondrial intermembrane space and is a well-characterized, specific and efficient catalyst of the reduction of protein-GSH mixed disulfides [19, 20] . The more recently identified Grx2 has three splice variants, Grx2a, Grx2b and Grx2c in humans and Grx2a, Grx2c and Grx2d in mice [21, 22] . Grx2a contains a mitochondrial localization sequence and is expressed ubiquitously in all tissues of both mice and humans. Grx2b and Grx2c in humans are localized in both the cytosol and nucleus and have been detected primarily in testes and cancer cell lines [23] . Mice, however, possess a Grx2c splice variant that is ubiquitously expressed in most tissues and a testes specific variant, Grx2d, which is not enzymatically active.
Grx2a is the best studied Grx2 splice variant in mammals and shares many characteristic features of Grx1, including a high specificity for glutathione-containing mixed disulfide and a double displacement kinetic mechanism [24] . Under oxidative stress conditions, (high ROS flux, low GSH, high GSSG levels), however, Grx1 can become inactivated due to the oxidation of non-catalytic cysteine residues, whereas Grx2a is highly stable and resistant to oxidative inactivation [25] . Inactivation of mitochondrial GR under these conditions is likely to further exacerbate thiol oxidative stress and promote S-glutathionylation of protein thiols. These observations suggest that Grx2a may play an important role in redox homeostasis of mitochondrial protein thiols, particularly under pathological conditions associated with increased oxidative stress such as atherosclerosis and other chronic inflammatory diseases.
The glutathione-dependent antioxidant system plays a critical role in protecting monocytes and macrophages against dysfunction and cell injury, thereby limiting macrophage accumulation at sites of vascular inflammation and preventing atherosclerotic lesion formation in mice. We reported that increased expression of Grx1 protects monocytes from priming, dysregulation and hypersensitization to chemokines induced by metabolic stress. We also showed that increased expression of either cytosolic or mitochondrial GR in macrophages reduces atherogenic lesion size in mice [26e28] . However, the role of mitochondrial Grx2a in macrophages and atherogenesis has not been studied.
To determine the role of monocytic mitochondrial Grx2a in atherosclerosis, we generated a novel transgenic mouse model (CD68-Grx2aTg mice), in which human mitochondrial Grx2a is expressed as an EGFP fusion protein under the control of the macrophage-specific CD68 promoter. To test our hypothesis that increased expression of Grx2a protects monocyte mitochondria from oxidative damage induced by metabolic stress, prevents monocyte priming and thus reduces atherosclerotic lesion formation, we crossed our transgenic mice (CD68-Grx2aTg mice) into the atherosclerosis-prone LDLR À/À mice (Grx2a Mac LDLRÀ/À ) and fed them a high fat diet for 14 weeks to induce atherosclerotic lesion formation. To our surprise, we found that increased expression of Grx2a was not atheroprotective and resulted in abnormal mitochondrial respiratory profiles and impaired mitochondrial function. Mitochondrial dysfunction in monocytes and macrophages, however, did not increase atherosclerotic lesion formation in these mice, suggesting that the partial loss of mitochondrial function is not sufficient to promote proatherogenic activities in monocytes and macrophages.
Materials and methods

Animals
C57BL/6 mice overexpressing a fusion protein of mitochondrial Grx2a fused with EGFP under the control of the macrophagespecific CD68 promoter were generated in collaboration with the Transgenic Core Facility at UT Southwestern Medical Center (Fig. 1) . Briefly, human Grx2a cDNA was excised by restriction enzyme and ligated to the EGFP sequence (Clontech), generating a fusion protein construct containing Grx2a and EGFP in the C-terminal. EGFP was then used as a marker for transgene expression. The Grx2a-EGFP sequence was then ligated into a vector containing the macrophage-specific CD68 promoter [29] , which carried the transgene on one allele, were crossed with atherosclerosis-prone LDLR À/À null mice to generate transgenic mice (Grx2a Mac LDLRÀ/À ) that overexpress Grx2a in monocytic cells and are prone to the 
Blood analysis
For monocyte subset analysis, blood was obtained by venous tail bleed prior to sacrifice. Plasma cholesterol and triglyceride levels were determined using enzymatic assay kits (Wako Chemicals) using blood obtained by cardiac puncture. For differential blood cell counts, cardiac blood was collected and blood cell counts were obtained on an Abaxis VetScan HM2 Complete Blood Count Analyzer.
Western blot
Transgene expression in CD68-Grx2aTg mice was evaluated by Western blot analysis. Briefly, peritoneal macrophages were isolated and lysed in MES-buffered saline with 1% triton X-100(MBST) and supplemented with protease inhibitor cocktail (Roche). Cell lysate proteins were separated by SDS-PAGE (12%) and both endogenous and transgenic Grx2a were detected using a rabbit-anti-human Grx2a antibody (a kind gift from Dr. John Mieyal, Case Western Reserve University, Cleveland) followed by anti-rabbit-HRP antibodies. Chemiluminescence was imaged and analyzed on a Kodak Imaging Station 4000 MM (Carestream Health).
Peritoneal macrophage isolation and purification
Resident peritoneal cells were harvested by lavage of the peritoneal cavity with 10 mL of ice-cold complete culture medium (RPMI 1640; Gibco BRL and Cellgro), final glucose concentration: 5 mM, supplemented with 2 mM/L L-alanyl-L-glutamine (GLUTA-MAX-1; Gibco BRL), 1% v/v nonessential amino acids (Gibco BRL), 1 mM sodium pyruvate (Gibco BRL), penicillin G/streptomycin (100 U/L and 100 mg/ml, respectively; Gibco BRL), 10 mM HEPES (Fluka) and with 2% fetal bovine serum (FBS) [26] . To obtain a cell population highly enriched in macrophages, peritoneal macrophages were purified by negative selection using antibody-coated magnetic beads (Dynabeads ® mouse pan B (B220) and Dynabeads ® mouse pan T (Thy 1.2)). This procedure routinely increased the macrophage content of the isolate from approximately 40% CD68-positive cells to greater than 95% CD68-positive cells. Purified peritoneal macrophages were then plated and maintained in culture media with 10% FBS.
Mitochondrial bioenergetic measurements and extracellular flux (XF) analysis in peritoneal macrophages
Bioenergetic measurements were conducted using the XF analyzer (Seahorse Bioscience, MA). Purified peritoneal macrophages were seeded in Seahorse Bioscience XF24 cell culture plates at a density of 250,000 cells per well. Preliminary cell seeding experiments demonstrated that a seeding density of 250,000 purified peritoneal macrophages allowed the formation of a single macrophage monolayer. In addition, the coefficient of variance (CV) between wells was below the 20% recommended by the manufacturer, and cells exhibited a baseline oxygen consumption rate (OCR) of 280 ± 14.8 pMoles/min. Prior to mitochondrial bioenergetic measurements, culture media was replaced with XF assay media (unbuffered RPMI) and macrophages were allowed a 1 h equilibration period at 37 C in an ambient CO 2 incubator not supplemented with additional CO 2 . OCR was monitored and realtime metabolic changes in cellular respiration were recorded in intact cells. To generate a mitochondrial respiratory profile, mitochondrial inhibitors including oligomycin (1.45 mM), FCCP (1.45 mM), and rotenone (10 mM) were sequentially added at 40 min intervals, and mitochondrial responses were monitored every 10 min following a cycle of 4 min measurement/4 min mixing/ 2 min delay. The following four respiratory parameters were utilized to analyze bioenergetic function according to the manufacturer's instructions: basal respiration, ATP turnover, proton leak, and maximal respiratory capacity.
Analysis of atherosclerosis
Grx2a Mac
LDLRÀ/À and Wt littermates (10e13 weeks of age) were fed a high fat diet (HFD fat 21% wt/wt and cholesterol 0.15% wt/wt; AIN-76A, BioServe) for 14 weeks. Two vascular beds were used for the analysis of atherosclerosis as we described previously [27] . Briefly, mice were euthanized and hearts and aortas were perfused with PBS through the left ventricle. Aortas were dissected from the proximal ascending aorta to the bifurcation of the iliac artery and fixed with 4% paraformaldehyde in PBS. Hearts were embedded in OCT and frozen on dry ice. For en face analysis, the adventitial fat was removed and aortas were opened longitudinally and digitally photographed at a fixed magnification. Total aortic area and lesion areas were calculated using ImagePro Plus 6.0 (Media Cybernetics) and expressed as percent lesion area. As a second measure of atherosclerosis, lesions of the aortic root were analyzed. Serial sections were cut through an 800 mm segment of the aortic root. For each mouse, 8 sections (10 mm) separated by 80 mm were examined. Each section was stained with oil red O (ORO), counterstained with hematoxylin (Vector Labs), and digitized. Lesion area was measured using ImagePro Plus 6.0 (Media Cybernetics) and expressed as millimeters squared. Macrophages were detected with anti-CD68 antibody (Serotech) and macrophage content in lesions was determined as the average CD68-positive area per total lesion area [30] .
Flow cytometry
To verify EGFP expression in whole blood monocytes of transgenic mice, red blood cells were lysed and Tg EGFP expression was analyzed by flow cytometry. For monocyte subset analysis, whole blood (40 mL) was washed with FACS buffer (PBS with 2% FBS and 0.05% NaN3) and incubated in CD16/CD32 mAb for 15 min at 4 C to block nonspecific binding. Cells were incubated with the surface APC-conjugated Gr-1 (Ly6-C and Ly6-G) at 4 C for 15 min. Red blood cells were lysed using BD FACS lysing solution (1:10). Cells were washed, and then fixed and permeabilized with BD Fixation and Permeabilization solution. All subsequent washes contained saponin (PBS with 1% BSA, 0.1% saponin, and 0.1% NaN 3 ) to maintain cell permeabilization. Cells were then stained with PE-conjugated CD68. Appropriate isotype controls were used to ensure specificity of antibodies used. The cells were analyzed using a BD FACSCalibur™ equipped for multi-color flow cytometry. Each measurement contained a defined number of 4 Â 10 5 cells. Data were analyzed using FlowJo software (Tree Star Inc., Ashland, OR).
Confocal microscopy of EGFP and Cox-IV co-localization
To verify the exclusively mitochondrial localization of the Grx2a-EGFP transgene, isolated peritoneal macrophages were stained with a rabbit polyclonal antibody to cytochrome c oxidase subunit 4 (COX-IV; 1:500 Abcam #16056) and Cy3 donkey antirabbit IgG (1:500). Confocal images were taken on an Olympus FV-1000 (60Â).
Viability assays
Resident peritoneal macrophages were harvested from wildtype C57BL/6 and transgenic Grx2aMac mice, purified and cultured for 24 h as described in section 2.4. Macrophages were treated for 9 h with either 20 mg/mL or 40 mg/mL 7-ketocholesterol (7 KC). Cells were then washed with PBS and lysed on ice in RIPA lysis buffer [50 mM Tris HCl (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate] supplemented with protease inhibitors (Roche). To determine the extent of apoptosis induced by 7 KC, lysates were assessed for caspase-3 activity using the fluorescent PARP substrate Ac-DECD-AFC (Enzo Life Sciences). The substrate was prepared as a 20 mM stock solution in DMSO according to manufacturer's instructions. Ten ml of stock substrate was added to 30 mg of cell lysate diluted in reaction buffer (20 mM HEPES, pH 7.5, 10% glycerol, 4 mM DTT). Reactions were incubated for 2 h at 37ᵒ C in black-walled 96-well clear bottom plates, and fluorescence was measured using a plate reader (Spectra MAX Gemini EM). Wells containing only reaction buffer plus substrate or lysate plus reaction buffer were used to normalize the values. Additionally, a reaction containing recombinant human caspase-3 (Sigma) was used as a control to test for substrate cleavage under these experimental conditions.
Mitochondrial superoxide assay
Mitochondrial superoxide production was assessed using the MitoSOX™ Red reagent (Life Technology) in purified peritoneal macrophages isolated from WT and Grx2a transgenic mice. Macrophages were plated in a 96-well cell culture plates at a cell density of 200,000 cells per well, washed and incubated with the MitoSOX reagent (5 mM working solution in 1Â HBSS generated from 5 mM stock solution in DMSO) for 10 min according to manufacturer's instructions. Mitochondrial superoxide production was quantified using a fluorescence plate reader (SpectraMAX; l ex ¼ 510 nm; l em ¼ 580 nm).
Statistical analysis
Data were analyzed using ANOVA (SigmaStat), unless stated otherwise. Data were tested for use of parametric or nonparametric post hoc analysis, and multiple comparisons were performed by using the least significant difference method. All data are presented as mean ± SE. Results were considered statistically significant at the P < 0.05 level.
Results
Transgenic Grx2a-EGFP expression is restricted to monocytic cells and localizes to mitochondria
To examine the role of the mitochondrial Grx2a on atherosclerosis, we generated a transgenic mouse model that overexpresses mitochondrially-targeted Grx2a as an EGFP fusion protein under the control of the monocyte/macrophage-specific CD68 promoter (Fig. 1) . Flow cytometry analysis showed that in blood, the transgene was expressed in 5.5% of total leukocytes and that all EGFP þ cells were CD115 þ , i.e. blood monocytes (Fig. 2) . To examine the expression of the transgene within the macrophages populations, purified peritoneal macrophages (CD68 þ ) were gated based on the expression of CD115 and F4/80. EGFP expression was detected in more than 73.9% of CD115 þ F4/80 þ cells (Fig. 3A) , demonstrating a high percentage of transgene expression within the macrophage population. The presence of the intact Grx2a-EGFP fusion protein was confirmed by Western blot analysis of protein lysates generated from purified peritoneal macrophages isolated from wildtype and Grx2a-EGFP transgenic mice (Fig. 3B ) [31] . To confirm that the transgene was targeted to mitochondria, we stained adherent peritoneal macrophages from wildtype and Grx2a-EGFP transgenic mice with antibodies directed against cytochrome c oxidase subunit 4 (Cox-lV), a mitochondrial marker. Confocal microscopy showed punctate EGFP expression in transgenic macrophages, and we observed the EGFP signal co-localize with Cox-IV (Fig. 4) .
Grx2a-EGFP transgenic mice showed no overt phenotype. Compared to their respective wildtype littermates, neither female nor male Tg mice showed any significant differences in bodyweight or total plasma cholesterol and triglyceride levels ( Table 1) . We also found no significant differences in the red blood cell, platelet or leukocyte counts or the lymphocyte and monocyte levels within the leukocyte population ( Table 2 ).
Increased expression of mitochondrial
Mitochondria are a source of ROS formation, which when unchecked promotes S-glutathionylation, resulting in decreased mitochondrial protein function, decreased ATP-linked mitochondrial oxygen consumption and reduced cellular bioenergetic reserve capacity [32] . We therefore predicted that in dyslipidemic LDL-R À/À mice, increasing the expression of Grx2a, the enzyme that catalyzes the de-glutathionylation of proteins in mitochondria, would protect metabolically stressed mitochondria against loss of protein function and improve mitochondrial respiratory efficiency.
To this end, LDL-R À/À and Grx2a Mac LDLRÀ/À mice were fed an HFD for 14 weeks after which peritoneal macrophages were isolated and analyzed for their mitochondrial respiratory activity. To our surprise, macrophages from Grx2a Mac LDLRÀ/À mice showed an ATP turnover rate that was 15% lower than the rate measured in macrophages from non-transgenic littermates (Fig. 5) , indicating that mitochondria in metabolically stressed macrophages overexpressing Grx2a were significantly less efficient in generating ATP than mitochondria in non-transgenic macrophages. In agreement with this finding, we also observed a lower maximal respiratory capacity in transgenic peritoneal macrophages, although this difference did not quite reach statistical significance (P ¼ 0.057). The proton leak is a measure of the endogenous leak of protons across the inner mitochondrial membrane which limits the proton motive force and could account for reduced ATP turnover rate. The proton leak was not altered by increased Grx2a expression, suggesting reduced ATP production was the result of a defect in mitochondrial electron transfer rather than increased uncoupling. Surprisingly, we observed no differences in MitoSox-sensitive mitochondrial ROS production between peritoneal macrophages isolated from wildtype and Grx2a Mac LDLRÀ/À mice (data not shown).
Nevertheless, our data show that increased expression of Grx2a impairs mitochondrial function in macrophages.
Increased expression of mitochondrial Grx2a increases sensitivity to oxysterol-induced apoptosis
To determine whether the reduced ATP turnover rate actually impaired biological functions in macrophages overexpressing Grx2a, we assessed whether macrophages from Grx2a-EGFP transgenic mice were more susceptible to oxysterol induced apoptosis. Indeed, macrophages from Grx2a-EGFP transgenic were significantly more sensitive to 7-KC-induced caspase-3 activation (Fig. 6 ). These data suggest that mitochondrial dysfunction induced by increased Grx2a expression results in increased sensitivity to oxysterol-induced apoptosis, possibly due to limited cellular ATP levels.
Increased expression of mitochondrial Grx2a does not prevent monocytosis induced by dyslipidemia
HFD-feeding induces monocytosis in atherosclerosis prone mice and elevated blood monocyte counts are a well-established independent risk factor in human vascular disease [33e35]. We therefore examined blood monocyte counts and monocyte subset distribution in Grx2a Mac LDLRÀ/À mice and LDLR À/À littermates, both before and after feeding an HFD for 14 weeks. Circulating blood leukocytes were analyzed by flow cytometry and cell populations were distinguished based on their expression of the monocytic lineage marker CD68 and the myeloid differentiation marker Gr-1 expressed on neutrophils and monocytes. Leukocyte subsets were defined as CD68 hi (monocytes) and CD68 lo (neutrophils), and monocytes were further divided into three subsets based on their expression level of Gr-1: CD68 mice from that reported in apoE À/À mice [36] . Overall, increased expression of Grx2a did not appear to affect monocytosis induced by metabolic stress, i.e. HFD-feeding, nor monocyte subset distributions. However, we noted a small but statistically significant difference in the percentage of patrolling monocytes between male LDL-R À/À and Grx2a Mac LDLRÀ/À mice after HFD feeding. The decrease in patrolling monocytes in Grx2a Mac LDLRÀ/À mice was small, but it is possible that with increasing gene dosage this effect may become larger and biologically significant.
Increased expression of mitochondrial Grx2a in macrophages does not affect atherosclerosis
Monocyte recruitment to sites of vascular injury is a ratelimiting step in the development and progression of atherosclerotic lesions. Transmigration of monocytes through the endothelium requires the activation of a large number of energy-dependent processes. Impaired mitochondrial ATP production in monocytes and macrophages may therefore impact the development and progression of atherosclerosis. En face analysis of the aortic root did not demonstrate any statistically significant difference in lesion size between Grx2a Mac LDLRÀ/À and non-transgenic littermates (Wt), neither in female nor male mice (Table 4) . We also observed no significant 
Discussion
The microenvironment in atherosclerotic plaques is proinflammatory and oxidative and can increase monocyte recruitment and impact macrophage differentiation, polarization, metabolism and survival. Under such oxidative conditions, ROSmediated protein thiol modifications in monocytes and macrophages, namely S-glutathionylation, has been reported to regulate protein activity and gene expression levels [37e39]. Protein Sglutathionylation is largely associated with increased cellular oxidative stress, however, more recently it has been recognized as an important redox signaling mechanism involved in the regulation of protein signaling cascades, regulating apoptosis, transcription, and metabolism and other cellular functions [40e44]. Glutaredoxins (Grx1 and Grx2) are largely responsible for catalyzing protein S-(de)glutathionylation reactions and altering the relative expression levels of these thiol transferases can have complex consequences on cellular processes. Overexpression of Grx2a, the mitochondrial form of Grx2, in human hepatocellular liver carcinoma cell line (HepG2) has profound protective effects with regard to cell viability, ROS production, and GSH/GSSG maintenance [45] . Doxorubicin-induced mitochondrial protein S-glutathionylation and cardiac injury in mice can also be prevented by overexpression of Grx2a [46] . Alternatively, cultured mouse lens epithelial cells isolated from Grx2 knockout animals display increased sensitivity to oxidative stress induced by hydrogen peroxide treatment [47] . Grx2 knockout cells develop mitochondrial dysfunction characterized by reduced ATP pools and enhanced complex 1 inactivation under both resting and oxidative stress conditions. Taken together, these observations support the notion that Grx2a plays a pivotal role in maintaining mitochondrial function under conditions of oxidative stress, suggesting the enzyme may also play important roles in the protection against chronic inflammatory diseases such as atherosclerosis.
We previously demonstrated that the cytosolic glutathionedependent antioxidant system plays a critical role in the recruitment of macrophages into the vascular wall and that this recruitment was associated with the formation of atherosclerotic plaques [28] . We also showed that overexpression in bone marrow-derived cells of glutathione reductase (GR), a homodimeric flavoprotein that maintains cellular thiol redox state by catalyzing the reduction of glutathione disulfide to glutathione, reduced atherosclerotic lesion formation by 32% [27] . Mitochondrial GR was found to be equally protective as the cytosolic enzyme, demonstrating that it is critical for macrophages to maintain their thiol redox balance in both compartments to prevent cell dysfunction or injury. In addition, we found that the increased expression of the cytosolic glutaredoxin (Grx1) completely blocked monocyte priming and dysfunction induced by either oxidative or metabolic stress [48] . These results demonstrate that the detrimental effects of oxidative and metabolic stress on monocyte migration and macrophage functions contributing to atherosclerotic lesion formation are mediated at least in part by changes in protein-S-glutathionylation. However, the role of Grx2a in maintaining monocyte and macrophage function under oxidative and metabolic stress, and the development of atherosclerosis was unknown. To determine the role of macrophage Grx2a, we therefore generated transgenic mice that overexpress Grx2a in monocytic cells (Grx2a Mac LDLRÀ/À mice) and are prone to the development of metabolic stress and atherosclerosis in response to high fat diet (HFD) feeding. Surprisingly, we observed no beneficial effect of increased Grx2a expression in macrophages on atherosclerotic lesion formation in animals after 14 weeks of HFD (Fig. 7) . This is in stark contrast to the beneficial effects we observed previously when overexpressing other members of the glutathione antioxidant system including GR and Grx1. Instead, we found that Grx2a overexpression in macrophages actually impairs mitochondrial respiration and ATP production (Fig. 5) . However, the 15% reduction in mitochondrial ATP turnover we observed is likely to have only minor consequences for macrophages, particularly if one considers that macrophages, particularly M1-activated macrophages, rely heavily on glycolysis [49] . This may explain why in our transgenic mice key functionalities of macrophages related to atherogenesis did not appear to be impaired by Grx2a overexpression. Our results suggest that contrary to our initial hypothesis, increased expression of Grx2a not only does not protect mitochondria during metabolic stress, but that by regenerating critical free thiols and maintaining them in a reduced state may actually disrupt mitochondrial functions. This conclusion is supported by our findings that Grx2a overexpression also sensitizes peritoneal macrophages to 7-ketocholestrolinduced apoptosis (Fig. 6) . Harper and colleagues were among the first to identify protein S-glutathionylation and Grx2 activity as regulators of mitochondrial function. Reversible protein S-glutationylation was found to act as a control switch for uncoupling protein 2 (UCP2) and uncoupling protein 3 (UCP3) activity in skeletal muscle, maintaining mitochondrial respiratory function under fluctuating redox conditions [50] . Furthermore, Grx2a appears to be required for UCP3 S-glutathionylation, which results in its inactivation and a Fig. 4 . Transgenic Grx2a-EGFP fusion protein localizes to mitochondria. Confocal microscopy images of peritoneal macrophages isolated from wildtype (Wt, left column) and transgenic CD68-Grx2aTg (Tg, right column) mice and labeled with the mitochondrial marker Cox-IV (red) and the nuclear dye DAPI (blue). EGFP expression is shown in green. Image overlay shows co-localization of EGFP with the mitochondrial marker Cox-IV. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) decrease in the proton leak. These observations demonstrate the importance of Grx2-mediated protein S-glutathionylation in regulating mitochondrial OXPHOS [42] . More recently, Grx2 was reported to also play a central role in regulating mitochondrial OXPHOS in cardiac muscle. Cardiomyocytes isolated from animals deficient in Grx2 demonstrated decreased ATP production along with increased (complex I, IV) and decreased (complex III, V) levels of mitochondrial complex proteins. Further analysis revealed that complex I levels could be restored by exogenous Grx1, indicating that deglutathionylation reactions mediated by Grx2 regulate mitochondrial complex levels [14] . Collectively, these observations, in conjunction with those reported in this study, suggest that Grx2a in cells such as monocytes and macrophages appears to play the role of a rheostat rather than a switch in regulating mitochondrial OXPHOS, and both its loss and over-expression may disrupt the subtle redox balance required for optimal mitochondrial function, and lead to mitochondrial dysfunction. Although previous reports have causally linked Grx1 and Grx2 activity to cardiovascular disease (enhanced cardioprotection in Grx1 and Grx2 transgenic mice), these studies have since been retracted, warranting further clarification of the exact role of these enzymes in maintaining protein thiol redox homeostasis in specific cell types (i.e monocytes and macrophages) during atherogenesis [51, 52] . Recent efforts to identify potential substrates of mammalian Grx2 not only led to the identification of numerous proteins with redox function but also, to an even larger number, of proteins with other functions in metabolism, nuclear transport, protein turnover, and transcription/translation [53, 54] . We now found that overexpression of Grx2a in macrophages appears to perturb rather than protect the mitochondrial protein S-glutathionylation/redox state, leading to the disruption of key metabolic processes. The beneficial effects of overexpressing antioxidant "protective" enzymes such as GR, Grx1 and Grx2a may thus be context specific and their roles in regulating cellular function via (de)-glutathionylation events are likely multifaceted. In summary, our data suggest that tight control are mean ± SD (n ¼ 3). *: P < 0.05 versus wildtype macrophages; **: P < 0.05 versus vehicle-treated wildtype macrophages (0 mg/ml). ) and patrolling monocytes (CD68 hi /Gr-1 lo ) are expressed as percent of total leukocyte counts. a P < 0.05, baseline vs. 14 weeks HFD. b P < 0.05, Wt (n ¼ 10) vs. Tg (n ¼ 13). of protein S-glutathionylation is essential for mitochondrial function and that both oxidative and reductive perturbations of the Sglutathionylation state of mitochondrial proteins appear to be detrimental to macrophage mitochondrial function, albeit with only limited impact on their atherogenic activity in vivo.
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